866 related articles for article (PubMed ID: 21242365)
1. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
2. Summaries for patients: Screening for liver cancer in patients with hepatitis C virus infection and cirrhosis.
Ann Intern Med; 2011 Jan; 154(2):I-36. PubMed ID: 21242351
[No Abstract] [Full Text] [Related]
3. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
4. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
5. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
[TBL] [Abstract][Full Text] [Related]
6. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C and hepatocellular carcinoma.
Fassio E
Ann Hepatol; 2010; 9 Suppl():119-22. PubMed ID: 20714008
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
Bruno S; Silini E; Crosignani A; Borzio F; Leandro G; Bono F; Asti M; Rossi S; Larghi A; Cerino A; Podda M; Mondelli MU
Hepatology; 1997 Mar; 25(3):754-8. PubMed ID: 9049231
[TBL] [Abstract][Full Text] [Related]
13. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
Chalasani N; Said A; Ness R; Hoen H; Lumeng L
Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
[TBL] [Abstract][Full Text] [Related]
14. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
15. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.
El-Serag HB; Kanwal F; Richardson P; Kramer J
Hepatology; 2016 Jul; 64(1):130-7. PubMed ID: 26946190
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma and hepatitis C in the United States.
El-Serag HB
Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
[TBL] [Abstract][Full Text] [Related]
18. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
20. Utilization of screening for hepatocellular carcinoma in the United States.
Davila JA; Weston A; Smalley W; El-Serag HB
J Clin Gastroenterol; 2007 Sep; 41(8):777-82. PubMed ID: 17700427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
